logo

Novartis Ag (NVS)



Trade NVS now with
  Date
  Headline
10/8/2019 1:41:05 AM Novartis Says FDA Approves Beovu Injection
10/2/2019 2:09:32 AM Novartis Announces Additional Positive Data From PREVENT Trial
10/1/2019 10:14:17 AM Novartis And Microsoft Collaborate To Transform Medicine With Artificial Intelligence
9/30/2019 1:29:43 AM Novartis Reports Positive Results From Phase III PALLADIUM Study
9/18/2019 8:34:53 AM Novartis Reports Positive Results From 5-year VERIFY Study In Type 2 Diabetes
9/17/2019 1:32:36 AM Novartis 16-week Phase III PREVENT Study Of ASAS40 Meets Primary Endpoint
9/13/2019 8:33:54 AM Novartis Phase III ASCLEPIOS Trials Demonstrate Robust Efficacy Of Ofatumumab In Patients With Relapsing MS
9/13/2019 8:22:13 AM Novartis Phase III ASCLEPIOS Trials Show Efficacy Of Ofatumumab In Relapsing MS
9/9/2019 1:23:00 AM Novartis Data Confirm Long-term Efficacy And Safety Of Aimovig
  
 
>